Literature DB >> 18317698

Poly(lactic-co-glycolic acid) nanosphere as a vehicle for gene delivery to human cord blood-derived mesenchymal stem cells: comparison with polyethylenimine.

So-Jung Gwak1, Byung-Soo Kim.   

Abstract

Polyethylenimine (PEI) is one of the most extensively studied non-viral vectors but its cytotoxicity limits its clinical value. PLGA nanospheres are biocompatible and can facilitate sustained release of plasmid DNA. This study compares the cytotoxicity and long-term transgene expression between PLGA nanosphere and PEI. PLGA nanospheres were significantly less cytotoxic than PEI at various concentrations. PLGA nanospheres induced significantly higher transgene expression in vitro for a longer duration (21 days) than PEI. We conclude that PLGA nanospheres have potential as gene delivery vehicles for use in gene therapy for diseases in which a long-term therapeutic gene expression regimen is necessary.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317698     DOI: 10.1007/s10529-008-9676-7

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  7 in total

1.  Environmental parameters influence non-viral transfection of human mesenchymal stem cells for tissue engineering applications.

Authors:  William J King; Nicholas A Kouris; Siyoung Choi; Brenda M Ogle; William L Murphy
Journal:  Cell Tissue Res       Date:  2012-01-26       Impact factor: 5.249

Review 2.  Physical non-viral gene delivery methods for tissue engineering.

Authors:  Adam J Mellott; M Laird Forrest; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2012-10-26       Impact factor: 3.934

3.  Polymeric nanoparticles for siRNA delivery and gene silencing.

Authors:  Yogesh Patil; Jayanth Panyam
Journal:  Int J Pharm       Date:  2008-10-01       Impact factor: 5.875

4.  Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.

Authors:  Sahar Eljack; Stephanie David; Areeg Faggad; Igor Chourpa; Emilie Allard-Vannier
Journal:  Int J Pharm X       Date:  2022-09-06

5.  PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.

Authors:  Wen-Pin Su; Fong-Yu Cheng; Dar-Bin Shieh; Chen-Sheng Yeh; Wu-Chou Su
Journal:  Int J Nanomedicine       Date:  2012-08-03

6.  Therapeutic Use of 3β-[N-(N',N'-Dimethylaminoethane) Carbamoyl] Cholesterol-Modified PLGA Nanospheres as Gene Delivery Vehicles for Spinal Cord Injury.

Authors:  So-Jung Gwak; Yeomin Yun; Do Heum Yoon; Keung Nyun Kim; Yoon Ha
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

7.  PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer.

Authors:  Chitra Risnayanti; Yeong-Su Jang; Jinju Lee; Hyung Jun Ahn
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.